Literature DB >> 16477484

Autonomic dysfunction in multiple sclerosis.

Carl-Albrecht Haensch1, Johannes Jörg.   

Abstract

Multiple sclerosis (MS) is the most frequent chronic neurological disease affecting young persons in developed countries. MS is, however, considered as a secondary cause, of central origin, for autonomic dysfunction. The most common autonomic symptoms in MS are disorders of micturation, impotence, sudomotor and gastrointestinal disturbances, orthostatic intolerance as well as sleep disorders. The majority of the patients suffer at some period of the disease from lower urinary tract symptoms and sexual dysfunction. Awareness and treatment of these conditions is vital to improving health and quality of life in patients with MS. The increased understanding of the pathophysiological mechanisms in autonomic dysfunction in MS, along with technological and pharmaceutical developments has advanced our ability to treat the multiple aspects complicating autonomic failure in MS.

Entities:  

Mesh:

Year:  2006        PMID: 16477484     DOI: 10.1007/s00415-006-1102-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  53 in total

1.  Cardiovascular dysfunction in multiple sclerosis.

Authors:  A R Acevedo; C Nava; N Arriada; A Violante; T Corona
Journal:  Acta Neurol Scand       Date:  2000-02       Impact factor: 3.209

2.  Gastric motility dysfunction in patients with multiple sclerosis assessed by gastric emptying scintigraphy.

Authors:  Tarek A F el-Maghraby; Neveen M Shalaby; Mohammed H Al-Tawdy; Seyam S Salem
Journal:  Can J Gastroenterol       Date:  2005-03       Impact factor: 3.522

3.  Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

Authors:  B Stankoff; E Waubant; C Confavreux; G Edan; M Debouverie; L Rumbach; T Moreau; J Pelletier; C Lubetzki; M Clanet
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

Review 4.  Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis.

Authors:  Oscar Fernández
Journal:  J Neurol       Date:  2002-01       Impact factor: 4.849

5.  Asymmetric sweating in a child with multiple sclerosis.

Authors:  M Ueno; Y Tokunaga; S Terachi; K Gondo; T Hara
Journal:  Pediatr Neurol       Date:  2000-07       Impact factor: 3.372

Review 6.  Fatigue in multiple sclerosis.

Authors:  L B Krupp; C Christodoulou
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

Review 7.  Fatigue in multiple sclerosis: a rational approach to evaluation and treatment.

Authors:  Jay H Rosenberg; Renata Shafor
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

Review 8.  Evaluation and treatment of autonomic disorders of the urogenital system.

Authors:  Apostolos N Apostolidis; Claire J Fowler
Journal:  Semin Neurol       Date:  2003-12       Impact factor: 3.420

Review 9.  Fatigue associated with multiple sclerosis: diagnosis, impact and management.

Authors:  Rohit Bakshi
Journal:  Mult Scler       Date:  2003-06       Impact factor: 6.312

10.  Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study.

Authors:  Udo A Zifko; Monika Rupp; Sigrid Schwarz; Harald T Zipko; Eva M Maida
Journal:  J Neurol       Date:  2002-08       Impact factor: 4.849

View more
  29 in total

1.  Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.

Authors:  Simona Petrescu; Raluca Trifanescu; Petru Ionescu; Gina Doinita Vanghelie; Radu Tanasescu; Mircea Moldovan; Nicolae Munjev; Ovidiu Bajenaru; Cristina Panea
Journal:  Maedica (Bucur)       Date:  2013-03

Review 2.  [Influence of neurological diseases on partnership and sexuality. Particularly in view of multiple sclerosis and Parkinson's disease].

Authors:  D Goecker; D Rösing; K M Beier
Journal:  Urologe A       Date:  2006-08       Impact factor: 0.639

3.  Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment.

Authors:  Zsolt Mezei; Laszlo Olah; Laszlo Kardos; Reka Katalin Kovacs; Laszlo Csiba; Tunde Csepany
Journal:  J Neurol       Date:  2013-06-12       Impact factor: 4.849

4.  Relapsing paralytic ileus in multiple sclerosis requiring surgery: a video case report.

Authors:  G Chiaro; C Fratila; F Martig; C Zecca; C Gobbi
Journal:  Clin Auton Res       Date:  2018-11-10       Impact factor: 4.435

Review 5.  Thermoregulation in multiple sclerosis.

Authors:  Scott L Davis; Thad E Wilson; Andrea T White; Elliot M Frohman
Journal:  J Appl Physiol (1985)       Date:  2010-07-29

6.  Morphological abnormalities of the recto-anal inhibitory reflex reflects symptom pattern in neurogenic bowel.

Authors:  Kumaran Thiruppathy; Amanda Roy; Giuseppe Preziosi; Jalesh Pannicker; Anton Emmanuel
Journal:  Dig Dis Sci       Date:  2012-03-18       Impact factor: 3.199

7.  The other bladder syndrome: underactive bladder.

Authors:  Minoru Miyazato; Naoki Yoshimura; Michael B Chancellor
Journal:  Rev Urol       Date:  2013

Review 8.  A step-wise approach to sperm retrieval in men with neurogenic anejaculation.

Authors:  Mikkel Fode; Dana A Ohl; Jens Sønksen
Journal:  Nat Rev Urol       Date:  2015-10-20       Impact factor: 14.432

9.  I-123 MIBG cardiac scintigraphy and autonomic test evaluation in multiple sclerosis patients.

Authors:  Mordechai Lorberboym; Yair Lampl; Galina Nikolov; Menachem Sadeh; Ronit Gilad
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

Review 10.  Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?

Authors:  Marco Cosentino; Franca Marino
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.